B · Normal
Novartis reported on November 19 that Novartis expects the compound annual growth rate of core product sales to reach 5% by 2031, and the core operating profit margin is expected to rise to more than 40% in 2029.
Global market intelligence 🕐 2026-11-19 14:03

Related telegraphs

Comments

0/500
Captcha (click to refresh)
No comments yet